NeuroSense Therapeutics (NRSN) Assets (2020 - 2026)
NeuroSense Therapeutics (NRSN) recorded Assets of $896,000 in Q2 2026, down 46.8% from $1.68 million a year earlier.
Powered by 
Analysis
NeuroSense Therapeutics (NRSN) Assets (2020 - 2026) Analysis & Trends
At the end of FY2025, NeuroSense Therapeutics reported Assets of $1.03 million, down 77.5% from FY2024.
- Annual Assets has a five-year compound annual growth rate of 5.7% (FY2020 to FY2025).
- Across earlier years, Assets came in at $4.58 million in FY2024 (+43.6%), $3.19 million in FY2023 (-58.7%), $7.72 million in FY2022 (-32.5%) and $11.43 million in FY2021.
- The Q2 2026 figure is the lowest quarterly Assets since Q4 2020.
- On a year-over-year basis, Assets rose in 1 of the last five quarters, with an average decline of 34.2%.
- Peak year-over-year performance for Assets in the last five years was growth of 43.6% in Q4 2024, against a decline of 81.7% in Q3 2024 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,168.10 Bn | 1,136.68 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 643.43 Bn | 561.95 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 500.92 Bn | 474.03 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 360.47 Bn | 314.85 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 302.41 Bn | 266.40 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 267.36 Bn | 241.05 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 241.30 Bn | 196.70 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 192.97 Bn | 167.17 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 171.65 Bn | 118.30 Bn | 10.94 Bn | 201.13 Bn |
| 10 | NeuroSense Therapeutics | 3.08 Mn | -1.36 Mn | - | 896,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 896,000.00 |
| Dec 31, 2025 | 1.03 Mn |
| Jun 30, 2025 | 1.68 Mn |
| Dec 31, 2024 | 4.58 Mn |
| Sep 30, 2024 | 984,000.00 |
| Jun 30, 2024 | 1.84 Mn |
| Mar 31, 2024 | 1.45 Mn |
| Dec 31, 2023 | 3.19 Mn |
| Sep 30, 2023 | 5.39 Mn |
| Jun 30, 2023 | 7.87 Mn |
| Mar 31, 2023 | 5.34 Mn |
| Dec 31, 2022 | 7.72 Mn |
| Sep 30, 2022 | 9.23 Mn |
| Jun 30, 2022 | 11.45 Mn |
| Mar 31, 2022 | 14.36 Mn |
| Dec 31, 2021 | 11.43 Mn |
| Dec 31, 2020 | 779,000.00 |
API Access
NeuroSense Therapeutics Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=NRSN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "NRSN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=NRSN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();